The Application of CAR-T Cell Therapy in Relapsed and Refractory Malignant Hematologic Tumors
Conditions
- Lymphoma, B-cell, Aggressive Non-Hodgkin (B-NHL)
- AML (Acute Myelogenous Leukemia)
- Myeloma Multiple
- B-ALL
- T-ALL/Lymphoma
- T-lymphocyte Lymphoma
Interventions
- DRUG: CAR-T Cells infusion（CAR2219,CAR2019, CAR19 etc）
Sponsor
Tianjin Medical University General Hospital
Collaborators